To study the effect of Nano Haritaki and Haritaki Choorna in Constipation.

An Open Labeled, Active Controlled, Randomized, Parallel Group Study Of Efficacy Of Nano Haritaki In Malavshtambha Vis-Ã?-Vis Functional Constipation

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013398

Enrollment

Registered

2018-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Functional constipation

Interventions

Intervention1: Nano Haritaki: 1gm dose at bed time for 14 days Control Intervention1: Haritaki Choorna: 5gm dose at bed time for 14 days

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having complaint Malavshtambha vis-a-vis functional constipation 2) Patient ready for the study and willing for treatment 3) Patient fulfilling Rome III criteria with symptoms Criteria fulfilled for the last 3 months with symptom onset at least 6 month prior to diagnosis.

Exclusion criteria

Exclusion criteria: 1) Pregnant and lactating women. 2) K/C/O uncontrolled Diabetes Mellitus, uncontrolled thyroid disorder, Renal failure, Anorectal disorders 3) Medication induced constipation eg. Iron suppliments etc.

Design outcomes

Primary

Measure	Time frame
1) To study the efficacy of Nano Haritaki in constipation by constipation assessment scale. 2) To study the efficacy of Haritaki in constipation by constipation assessment scale. 3) To compare the efficacy of Nano Haritaki and Haritaki in constipation by constipation assessment scale.Timepoint: 1)at baseline, 7th day & 14th day. 2)at baseline, 7th day & 14th day. 3)at baseline, 7th day & 14th day.	—

Measure

Time frame

1) To study the efficacy of Nano Haritaki in constipation by constipation assessment scale. 2) To study the efficacy of Haritaki in constipation by constipation assessment scale. 3) To compare the efficacy of Nano Haritaki and Haritaki in constipation by constipation assessment scale.Timepoint: 1)at baseline, 7th day & 14th day. 2)at baseline, 7th day & 14th day. 3)at baseline, 7th day & 14th day.

—

Secondary

Measure	Time frame
1)To study the effect of Nano Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. 2)To study the effect of Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. 3)To compare the efficacy of Nano Haritaki and Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. Timepoint: 1)at baseline, 7th day, 14th day 2)at baseline, 7th day, 14th day 3)at baseline, 7th day, 14th day	—

Measure

Time frame

1)To study the effect of Nano Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. 2)To study the effect of Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. 3)To compare the efficacy of Nano Haritaki and Haritaki in constipation by assessing Quality of Life â?? patients of constipation questionnaire. Timepoint: 1)at baseline, 7th day, 14th day 2)at baseline, 7th day, 14th day 3)at baseline, 7th day, 14th day

—

Countries

India

Contacts

Public ContactDr Neha Vijay Jagtap

Sumatibhai Shah Ayurved Mahavidyalaya

dr.vaishalid@gmail.com9096082950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026